Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jul 14, 2020; 26(26): 3800-3813
Published online Jul 14, 2020. doi: 10.3748/wjg.v26.i26.3800
Table 2 Univariate analysis of risk factors associated with transmural bowel infarction in the training cohort
VariableOR (95%CI)P value
Age, yr0.97 (0.95-0.99)0.01
Gender, male vs female2.22 (1.06-4.65)0.03
Tobacco use1.03 (0.48-2.23)0.94
Hypertension1.10 (0.38-3.20)0.86
Diabetes3.85 (0.86-17.14)0.08
Ischemic heart disease2.81 (0.34-23.36)0.34
Previous history of DVT3.14 (1.53-6.47)0.002
Malignant disease0.41 (0.21-1.78)0.99
Diarrhea1.04 (0.39-2.81)0.93
Hematochezia2.53 (1.33-4.79)0.004
Fever1.16 (0.47-2.83)0.75
Abdominal distention3.56 (1.82-6.97)< 0.001
Abdominal tenderness7.25 (3.40-15.46)< 0.001
Rebound tenderness9.14 (4.17-20.04)< 0.001
White blood cells, > 10 × 109/L vs ≤ 10 × 109/L1.12 (1.06-1.17)< 0.001
Hemoglobin, > 120 g/L vs ≤ 120 g/L1.01 (1.00-1.02)0.35
Platelets, > 100 × 109/L vs ≤ 100 × 109/L1.00 (0.99-1.01)0.96
C-reactive protein, > 50 mg/L vs ≤ 50 mg/L1.02 (1.01-1.02)0.05
Serum lactate levels, > 2 mmol/L vs ≤ 2 mmol/L6.53 (3.27-13.04)< 0.001
Creatinine, > 106 µmol/L vs ≤ 106 µmol/L2.05 (0.96-4.41)0.07
D-dimer, > 0.5 mg/L vs ≤ 0.5 mg/L1.00 (1.00-1.01)0.50
Procalcitonin, > 0.5 µg/L vs ≤ 0.5 µg/L1.02 (0.92-1.12)0.72
Distal thrombosis2.13 (1.07-4.36)0.02
Portal vein or/and splenic vein extension1.01 (0.52-1.94)0.98
Decreased bowel wall enhancement9.00 (4.24-19.12)< 0.001
Bowel wall thickening1.99 (0.98-2.01)0.24
Bowel loop dilation2.21 (1.67-3.54)0.03
Pneumatosis intestinalis1.36 (1.23-3.15)0.04
Ascites1.40 (0.76-2.58)0.28
Recent surgery1.13 (0.54-2.38)0.74
Intraperitoneal inflammation1.63 (0.84-3.16)0.15
Liver cirrhosis2.44 (1.28-4.68)0.007